SCHEMBL3973501

SCHEMBL3973501

CCc1cc(O)c(O)c(-c2nnc(S)n2-c2ccc3nc(C)n(CC)c3c2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.34
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
KMT2A Q03164 3/20 0.33
POLB P06746 3/20 0.33
MAPT P10636 3/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
THRB P10828 1/20 0.33
PKM P14618 1/20 0.33
MAPK1 P28482 1/20 0.33
MPI P34949 1/20 0.33
BLM P54132 1/20 0.33
RAD52 P43351 1/20 0.33
ACSS2 Q9NR19 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALPL P05186 1/20 0.32
ALPI P09923 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL419819 0.84 KMT2A (0.36) KDM4EHDAC1HDAC8KMT2APOLB
SCHEMBL419127 0.77 KMT2A (0.44) KDM4EHDAC1HDAC8KMT2APOLB
SCHEMBL4664286 0.72 ESR1 (0.34) KMT2AMAPTMEN1ALDH1A1L3MBTL1
SCHEMBL4472095 0.72 MAPT (0.35) MAPTESR1ESR2
SCHEMBL1148641 0.71 KDM4E (0.37) KDM4EHDAC1HDAC8KMT2APOLB
SCHEMBL1305425 0.70 KDM4E (0.38) KDM4EHDAC1HDAC8KMT2APOLB
SCHEMBL16772875 0.69 HSP90AA1 (0.37) KDM4EHDAC1HDAC8KMT2APOLB
SCHEMBL19312436 0.68 ACSS2 (0.55) KDM4EKMT2AMAPTALDH1A1GAA
SCHEMBL942468 0.65 KDM4E (0.39) KDM4EKMT2APOLBMAPTMEN1
SCHEMBL13983173 0.65 TRPA1 (0.33) ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054059-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY Synta Pharmaceuticals Corporation (US) 2009-05-06 EP claimed
WO-2008021364-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2008-02-21 WO claimed
EP-2054059-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY Synta Pharmaceuticals Corporation (US) 2009-05-06 EP disclosed
WO-2008021364-A2 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY SYNTA PHARMACEUTICALS CORP. (US) 2008-02-21 WO disclosed